Fluarix Tetra 15 µg / 0.5 ml, Injektionssuspension

7680629610359 CH-62961 Injektionssuspension

Associated product:

Fluarix Tetra susp inj av aig sép 2025/2026 ser pré 0.5 ml, , Fluarix Tetra susp inj av aig sép 2025/2026 ser pré 0.5 ml

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
01/09/2026
Summary of Product Characteristics
Français
01/09/2026
Summary of Product Characteristics
Italien
01/09/2026

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
polysorbatum 80
- Substance HNIDK
octoxinolum-10
- Substance HNIDK
natrii chloridum
- Substance HNIDK
magnesii chloridum hexahydricum
- Substance HNIDK
dinatrii phosphas dodecahydricus
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
kalii chloridum
- Substance HNIDK
alpha-tocopheroli hydrogenosuccinas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.66 MG Substance HBESI
kalium
0.11 MG Substance HBESI
ovalbuminum
- Substance RESI
formaldehydum
- Substance RESI
natrii desoxycholas
- Substance RESI
gentamicini sulfas
- Substance RESI
hydrocortisonum
- Substance RESI

Reimbursement information

Public price
CHF 26.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2025

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
62961
Drug name
Fluarix Tetra, Injektionssuspension
Galenic form
SUPA
ATC Code
J07BB02
Authorization status
Z
Dispensing category
B
First authorization
28/05/2014
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Influenza, ab 36 Monaten

Package details

Description (FR)
FLUARIX Tetra 15 µg / 0.5 ml susp inj 15 µg 1 pce
Description (DE)
FLUARIX Tetra 15 µg / 0.5 ml Inj Susp 15 µg 1 Stk
Market launch
16/09/2025
Market withdrawal
31/12/2025
Narcotic (BTM)
No

Other package sizes (10)

FLUARIX TETRA av aig fix 2014/2015 0.5 ml
1 x 0.5 ml FESP
GTIN: 7680629610014
Not in V1
None
10 x 0.5 ml FESP
GTIN: None
Not in V1
None
1 x 0.5 ml FESP
GTIN: None
Not in V1
None
10 x 0.5 ml FESP
GTIN: None
Not in V1
None
1 x 0.5 ml FESP
GTIN: None
Not in V1
None
10 x 0.5 ml FESP
GTIN: None
Not in V1
None
1 x 0.5 ml FESP
GTIN: None
Not in V1
None
10 x 0.5 ml FESP
GTIN: None
Not in V1
FLUARIX TETRA av aig fix 2015/2016 0.5 ml
1 x 0.5 ml FESP
GTIN: 7680629610090
Not in V1
FLUARIX TETRA av aig fix 2015/2016 10 x 0.5 ml
10 x 0.5 ml FESP
GTIN: 7680629610106
Not in V1
Buy us a coffee Explore the data